United States Surgical Sutures Market Outlook to 2033 - Automated Suturing Devices and Sutures
Summary
GlobalData’s “United States Surgical Sutures Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Surgical Sutures market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Automated Suturing Devices and Sutures
The United States Surgical Sutures Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Surgical Sutures Market.
Global corporate-level profiles of key companies operating within the United States Surgical Sutures Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Surgical Sutures is segmented as follows -
Automated Suturing Devices
Sutures
Reasons to Buy
The United States Surgical Sutures Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Surgical Sutures Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Surgical Sutures Market, United States
3.1 Surgical Sutures Market, United States, Revenue ($m), 2018-2033
3.1.1 Automated Suturing Devices Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Sutures Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Surgical Sutures Market, United States, Volume (Units), 2018-2033
3.2.1 Automated Suturing Devices Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Sutures Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Surgical Sutures Market, United States, Average Price ($) , 2018-2033
3.4 Surgical Sutures Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Surgical Sutures Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Surgical Sutures Market
4.1 Ethicon Inc
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 LSI SOLUTIONS Inc
4.4.1 Company Overview
4.5 Arthrex Inc
4.5.1 Company Overview
4.6 Smith & Nephew Plc
4.6.1 Company Overview
4.7 B. Braun Melsungen AG
4.7.1 Company Overview
4.8 Peters Surgical
4.8.1 Company Overview
5 Surgical Sutures Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Merit Medical Raises USD650 Million in Private Placement of 3% Convertible Senior Notes Due 2029
6.2 Equity Offerings
6.2.1 BioRestorative Therapies Files Prospectus to Raise Upto USD3.34 Million in Public Offering of Shares
6.2.2 BioRestorative Therapies to Raise USD8.1 Million in Private Placement of Shares
6.3 Venture Financing
6.3.1 Merit Medicine System Raises USD2 Million in Seed Financing
7 Recent Developments
7.1 Financial Announcements
7.1.1 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
7.1.2 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
7.2 Legal And Regulatory
7.2.1 Dec 26, 2023: CVRx receives FDA approval for expanded labeling of Barostim
7.2.2 Nov 14, 2023: John Muir Health and Ambience Healthcare Launch End-to-End Epic EHR Integrations with Generative AI
7.3 Other Significant Developments
7.3.1 Feb 21, 2024: Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
7.3.2 Dec 26, 2023: MedMira Receives 510(k) Clearance for Reveal G4 Rapid HIV-1/2 Antibody Test
7.3.3 Nov 30, 2023: Innosphere Ventures Fund Announces Major Investment in GelSana to Revolutionize Advanced Wound Care
7.4 Product News
7.4.1 Apr 11, 2024: Neurelis Announces Two Poster Presentations at the 76th Annual Meeting of the American Academy of Neurology